st 679 has been researched along with celecoxib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandova, A; Georgieva, A; Kesiova, M; Kirkova, M; Todorov, S; Tsvetanova, E | 1 |
| Alexandova, A; Kesiova, M; Kirkova, M; Todorov, S | 1 |
2 other study(ies) available for st 679 and celecoxib
| Article | Year |
|---|---|
Potential antioxidant activity of celecoxib and amtolmetin guacyl: in vitro studies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Celecoxib; Deoxyribose; Free Radicals; Gastric Mucosa; Glycine; Intestinal Mucosa; Liver; Male; Nitroblue Tetrazolium; Oxidation-Reduction; Pyrazoles; Pyrroles; Rats; Rats, Wistar; Sulfonamides | 2007 |
In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Catalase; Celecoxib; Colon; Cyclooxygenase 2 Inhibitors; Diclofenac; Gastric Mucosa; Glucosephosphate Dehydrogenase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glycine; Lipid Peroxidation; Liver; Male; Oxyphenonium; Pyrazoles; Pyrroles; Rats; Rats, Wistar; Sulfhydryl Compounds; Sulfonamides; Thiobarbituric Acid Reactive Substances; Tolmetin | 2007 |